Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Imagine Pharma LLC operates within the Biotechnology & Pharmaceuticals technology area with a very narrow prosecution footprint. The data indicates 1 pending office action currently active across the entire portfolio. This single matter is assigned to 1 distinct examiner, reflecting a lack of broad distribution in current patent office interactions for the company. The absence of multiple examiners suggests that the company's current legal focus is limited to a specific niche within the broader biotechnology sector.
The busiest examiner for this portfolio is HUTSON, RICHARD G, who is managing the 1 pending office action. Prosecution is confined to 1 distinct art unit, which suggests that the company's current filings are being evaluated within a single specialized group. For practitioners, this means that the outcome of the portfolio's active prosecution depends entirely on the decisions of this one examiner. The 1 busiest examiner pending action count matches the total pending actions, confirming that no other officials are currently reviewing the company's applications in this set.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUTSON, RICHARD G | 1 | 65.1% | +53.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17892224 | COMPOSITIONS AND METHODS FOR TREATING DIABETES, HYPERTENSION AND HYPERCHOLESTEROLEMIA | HUTSON, RICHARD G | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17892224 | COMPOSITIONS AND METHODS FOR TREATING DIABETES, HYPERTENSION AND HYPERCHOLESTEROLEMIA | HUTSON, RICHARD G | — |
| Art Unit | Apps |
|---|---|
| 1652 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17892224 | COMPOSITIONS AND METHODS FOR TREATING DIABETES, HYPERTENSION AND HYPERCHOLESTEROLEMIA | HUTSON, RICHARD G | 1652 | §101§102DP | Final Rejection | — | Pending | Aug 22, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialImagine Pharma LLC has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Richard G Hutson has the most, with 1 of Imagine Pharma LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.